1-86360428-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001366781.1(ODF2L):āc.1165C>Gā(p.Gln389Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000803 in 1,246,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001366781.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODF2L | NM_001366781.1 | c.1165C>G | p.Gln389Glu | missense_variant, splice_region_variant | 11/17 | ENST00000460698.7 | NP_001353710.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ODF2L | ENST00000460698.7 | c.1165C>G | p.Gln389Glu | missense_variant, splice_region_variant | 11/17 | 5 | NM_001366781.1 | ENSP00000433092.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000433 AC: 1AN: 231124Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 125186
GnomAD4 exome AF: 8.03e-7 AC: 1AN: 1246042Hom.: 0 Cov.: 18 AF XY: 0.00 AC XY: 0AN XY: 629804
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.1252C>G (p.Q418E) alteration is located in exon 12 (coding exon 11) of the ODF2L gene. This alteration results from a C to G substitution at nucleotide position 1252, causing the glutamine (Q) at amino acid position 418 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at